Notice: This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsEarningsInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ContextLogic Inc. Reports Third-Quarter 2024 Financial ResultsNovember 7, 2024 | globenewswire.comLGCB Linkage Global IncSeptember 15, 2024 | seekingalpha.comContextLogic Inc. Reports Second-Quarter Financial ResultsAugust 8, 2024 | globenewswire.comLogicBio Therapeutics, Inc. (LOGC)May 14, 2024 | finance.yahoo.comRVVTF Revive Therapeutics Ltd.March 27, 2024 | seekingalpha.comLogicBio's IPO: What You Need To KnowSeptember 24, 2023 | finance.yahoo.comRare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports LtdMarch 31, 2023 | uk.finance.yahoo.comAlexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® TherapeuticsNovember 16, 2022 | finance.yahoo.comTrading was temporarily halted for "LOGC" at 07:11 PM with a stated reason of "News pending."November 16, 2022 | marketbeat.comLogicBio Therapeutics, Inc.: LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNovember 14, 2022 | finanznachrichten.deLogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNovember 14, 2022 | finance.yahoo.comShort Volatility Alert: LogicBio Therapeutics, Inc.November 7, 2022 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, IMRA, SBTXOctober 17, 2022 | marketwatch.comINVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of LogicBio Therapeutics, Inc. - LOGCOctober 4, 2022 | benzinga.comLooking Into LogicBio Therapeutics's Recent Short InterestOctober 3, 2022 | msn.comLogicBio Therapeutics Shares Soar on Takeover by AstraZeneca >LOGCOctober 3, 2022 | marketwatch.comAstraZeneca acquires local startup at 660% premiumOctober 3, 2022 | bizjournals.comLogicBio's stock skyrockets after buyout bid for a 667% premiumOctober 3, 2022 | finance.yahoo.comAstraZeneca pays 660% premium for gene therapy firm LogicBioOctober 3, 2022 | msn.comLogicBio To Be Bought By Alexion, AstraZeneca Rare DiseaseOctober 3, 2022 | nasdaq.comAstraZeneca to Buy LogicBio Therapeutics for $68 Million >LOGCOctober 3, 2022 | marketwatch.comWhy LogicBio Therapeutics Stock Is Soaring TodayOctober 3, 2022 | msn.comAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineOctober 3, 2022 | finance.yahoo.comLogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONESeptember 21, 2022 | finance.yahoo.comLogicBio Therapeutics IncSeptember 1, 2022 | reuters.comEarnings Update: LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Just Reported And Analysts Are Boosting Their EstimatesAugust 18, 2022 | finance.yahoo.comRecap: LogicBio Therapeutics Q2 EarningsAugust 16, 2022 | benzinga.comLogicBio Therapeutics (LOGC) Moves to Buy: Rationale Behind the UpgradeJuly 27, 2022 | finance.yahoo.comLogicBio Therapeutics Inc - Stock Quote LOGCJune 14, 2022 | morningstar.comLogicBio® Therapeutics to Present at H.C. Wainwright Global Investment ConferenceMay 17, 2022 | finance.yahoo.comLogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business UpdatesMay 16, 2022 | finance.yahoo.comLogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual MeetingMay 11, 2022 | finance.yahoo.comWhy LogicBio Therapeutics Shares Are Popping Off TodayMay 9, 2022 | uk.investing.comLogicBio Says FDA Lifts Clinical Hold On LB-001 INDMay 9, 2022 | markets.businessinsider.comClinical Development Update from Portfolio Company LogicBioMay 9, 2022 | markets.businessinsider.comLogicBio surges as FDA lifts clinical hold on lead assetMay 9, 2022 | seekingalpha.comLogicBio Therapeutics Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic AcidemiaMay 9, 2022 | finance.yahoo.comLogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric TrialMay 9, 2022 | finance.yahoo.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.38%April 27, 2022 | msn.comLogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing ConferenceMarch 23, 2022 | finance.yahoo.comLogicBio Therapeutics's Return On Capital Employed InsightsMarch 12, 2022 | benzinga.comLogicBio Therapeutics to Present at Barclays Global Healthcare ConferenceMarch 8, 2022 | finance.yahoo.comLogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business UpdatesMarch 4, 2022 | finance.yahoo.comAgenus (AGEN) Reports Q4 Loss, Lags Revenue EstimatesMarch 1, 2022 | finance.yahoo.comUniQure (QURE) Tops Q4 Earnings and Revenue EstimatesFebruary 25, 2022 | finance.yahoo.comLogicBio downgraded at William Blair citing lack of clarity on catalysts after clinical holdFebruary 3, 2022 | seekingalpha.comAnalyst Ratings For LogicBio TherapeuticsFebruary 2, 2022 | markets.businessinsider.comWhy Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?February 2, 2022 | finance.yahoo.comGene-editing company shares drop by one-third after clinical holdFebruary 2, 2022 | finance.yahoo.comArix Bioscience PLC: Clinical development update from portfolio company LogicBioFebruary 2, 2022 | finanznachrichten.de Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now LOGC Media Mentions By Week LOGC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LOGC News Sentiment▼0.000.66▲Average Retail/Wholesale News Sentiment LOGC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LOGC Articles This Week▼00▲LOGC Articles Average Week Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Editas Medicine News Beyond News ThredUp News 1stdibs.Com News uniQure News Voyager Therapeutics News Hour Loop News Meiwu Technology News Onion Global News Sangamo Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LOGC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LOGC Stock Alerts